Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus

Fig. 4

Sensitivity analysis stratified by the medications at admission. Adjusted for smoking history, hypertension, T2DM, previous MI, previous PCI, previous stroke, clinical diagnosis, TC, hs-CRP, eGFR, HbA1c, LVEF, ACEI/ARB at discharge, oral antidiabetic agents at discharge, insulin at discharge, LM disease, three-vessel disease, chronic total occlusion, SYNTAX score, complete revascularization, and number of stents. The HR was examined by evaluating 1 normalized unit increase. IR insulin resistance, TyG triglyceride-glucose, VAI visceral adiposity index, CVAI Chinese visceral adiposity index, LAP lipid accumulation product, TG/HDL-C triglyceride-to-high density lipoprotein cholesterol ratio, HR hazard ratio, CI confidence interval

Back to article page